Look for:

Our offer for

SEAGEN INC.


ISIN:
US81181C1045
WKN:
81181C104

2021/11/26 08:08:26
Price
150.76 EUR
Difference -1.64% (-2.52)

General attributes

ISINUS81181C1045
SymbolSGEN
ExchangeBerlin
CurrencyEUR
SectorOther
Security typeStock
Market cap (m)27,387 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)148.94 EUR (40)
Ask (Ask size)152.10 EUR (39)
Open150.76 EUR
High150.76 EUR
Low150.76 EUR
Close (prev. day)153.28 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades2
Last size0

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: SEAGEN INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2021/11/26 08:08:26
Price
150.76 EUR
Difference -1.64% (-2.52)

General attributes

ISINUS81181C1045
SymbolSGEN
ExchangeBerlin
CurrencyEUR
SectorOther
Security typeStock
Market cap (m)27,387 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)148.94 EUR (40)
Ask (Ask size)152.10 EUR (39)
Open150.76 EUR
High150.76 EUR
Low150.76 EUR
Close (prev. day)153.28 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades2
Last size0

Performance and Risk

6m1Y3Y
Perf (%)+24.78%+10.90%+194.11%
Perf (abs.)+29.94+14.82+99.50
Beta0.280.630.76
Volatility29.5738.9145.64
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)155.00 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)154.54 EUR (1)
Ø price 100 days | Ø volume 100 days (pcs.)139.05 EUR (6)
Ø price 250 days | Ø volume 250 days (pcs.)133.42 EUR (7)
YTD High | date163.84 EUR (2021/11/08)
YTD Low | date109.88 EUR (2021/05/11)
52 Weeks High | date163.84 EUR (2021/11/08)
52 Weeks Low | date109.88 EUR (2021/05/11)

All listings for SEAGEN INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2021/11/2622:26151.00 EUR0.0815
Stuttgart2021/11/2619:05148.96 EUR0.0019
Nasdaq2021/11/2619:00169.50 USD126.4613,275
Munich2021/11/2608:06151.02 EUR0.002
London Stock Exchange2021/11/0915:31189.00 USD0.021
Frankfurt2021/11/2615:31156.24 EUR0.003
Berlin2021/11/2608:08150.76 EUR0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=137070&ID_TYPE_IMAGE_LOGO=2

Contact Details

SEAGEN INC.
- -
21823-30th Drive SE - 98021 Bothell
Telefon: 1-425-527-4000
Fax: -
E-mail: contact@seagen.com

PDF Downloads

Company report: SEAGEN INC.PDF Download

Company Profile

Seagen Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.

Members of Management Board

Alpna SethMember of Board of Directors
Felix BakerMember of Board of Directors
Marc LippmanMember of Board of Directors
Nancy SimonianMember of Board of Directors
Ted LoveMember of Board of Directors
Daniel WelchMember of Board of Directors
David GryskaMember of Board of Directors
John OrwinMember of Board of Directors
Clay B. SiegallChairman of Managing Board
Vaughn B. HimesMember of Executive Committee
Charles RompMember of Executive Committee
Christopher PawlowiczMember of Executive Committee
Jean I. LiuMember of Executive Committee
Natasha HerndayMember of Executive Committee
Roger D. Dansey, M.D.Member of Executive Committee
Todd E. SimpsonMember of Executive Committee
Tuomo PätsiMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer